An antiseptic is a substance that kills or hampers growth of harmful microorganisms. These are used in hospitals and other medical settings to reduce the risk of infection during surgery and other medical procedures. Antiseptic products are used on the skin of living organisms and are also called skin disinfectants. Antiseptics have several advantages owing to their antimicrobial properties. Most of the antiseptics are over-the-counter (OTC) products, which are easily available for use at home and in hospital settings. Initiatives take by governments to reduce cases of healthcare-associated infections (HAIs) by creating awareness about home and personal hygiene are expected to create growth opportunities for market players.
The global antiseptic market size was valued at US$ 4,448.9 million in 2019, and is expected to witness a CAGR of 5.1% over the forecast period (2019 – 2027).
Global Antiseptic Market Share (%) Analysis, By Application, 2019
Source: Coherent Market Insights Analysis (2019)
Increasing Use of Antiseptics to Control Healthcare Acquired Infections And Surgical Site Infections Is Expected To Drive Growth of the Global Antiseptic Market
The antiseptic market is expected to witness growth over the forecast period owing to increasing use of antiseptic products for pre-operative and post-operative procedures, as antiseptic products control healthcare acquired infections (HAIs) and surgical site infections (SSIs). For instance, according to the National Centre for Disease Control (CDC) report, in 2017, the most common HAIs in India were urinary tract infections, surgical site infections, hospital associated pneumonia, hospital associated blood stream infections and others. Moreover, according to the same source, the prevalence of hospital associated urinary tract infections in India is around 35-45% per year.
Global Antiseptic Market - Restraints
There are stringent rules and regulations imposed on the use of antiseptics in hospitals and home settings owing to harmful effects caused by chemical compounds. Certain chemical compounds used in antiseptics are not safe and effective for use in over-the-counter (OTC) health care antiseptic products.
Stringent regulations proposed by the U.S. Food and Drug Administration (FDA) on OTC antiseptic products are expected to hamper growth of the global antiseptic market over the forecast period. For instance, in 2017, the U.S. FDA banned 24 antibacterial active ingredients from use in over-the-counter healthcare antiseptics, which included triclosan and several iodine-based compounds such as iodine tincture, iodine topical solution, poloxamer-iodine complex, and others.
Global Antiseptic Market - Regional Insights
On the basis of region, the global antiseptic market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the global antiseptic market owing to increasing healthcare expenditure. For instance, according to the U.S. National Health Expenditures Highlights of 2017, healthcare expenditure in the U.S. increased by 4.6% to US$ 1.1 trillion in 2017.
Asia Pacific is the fastest growing region in the global antiseptic market owing to increasing product launches in India which is expected to drive growth of the antiseptic market in Asia Pacific. For instance, in September 2018, ITC Limited, an Indian multinational conglomerate company, entered the health and hygiene sector by launching the Savlon hand sanitizer pen spray in India.
Global Antiseptic Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Source: Coherent Market Insights Analysis (2019)
Global Antiseptic Market - Competitive Landscape
An antiseptic is a chemical agent that stops the growth of microorganisms on external surfaces of the body, and helps to prevent infections. Antiseptics are also referred to as skin disinfectants. However, chemical agents can be used as an antiseptic and disinfectants depending on their concentration. For example, hydrogen peroxide 6% solution is used for cleansing wounds, while stronger solutions (>30%) are used in the industry as bleach and oxidizing agent. The high prevalence and incidence of hospital-acquired infections have increased the awareness on hygiene among healthcare professional, whereas rising concerns over the spread of infectious diseases in residential, commercial (or industrial), and healthcare units have led to increasing preference for private clinics and hospitals among the populace. These factors are expected to drive growth of the antiseptic market in the near future.
Increasing cases of healthcare-associated infections (HAIs) are also expected to drive growth of the antiseptic market over the forecast period. For instance, according to the Centers for Disease Control and Prevention 2017 report, each year, around 1 in 25 U.S. hospital patients are diagnosed with at least one infection related to hospital care. Many healthcare-associated infections (HAIs) are caused by the antibiotic-resistant (AR) bacteria, which may lead to sepsis or death.
However, stringent regulations proposed by the U.S. Food and Drug Administration (FDA) for OTC antiseptic products are expected to hamper growth of the antiseptic market during the forecast period. For instance, in 2015, the U.S. FDA announced that Triclosan and other 23 active ingredients are not classified as 'Generally Recognized as Safe and Effective (GRASE)' to be used in OTC health care antiseptic products.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.